Tonix Pharmaceuticals stock halted ahead of FDA approval news
Vivos Inc (EXCHANGE:RDGL) CEO and President Michael K. Korenko, according to a Form 4 filing, has purchased 100,000 shares of common stock on August 14, 2025. The shares were bought at a price of $0.0766, for a total transaction value of $7,660. The purchase comes as the stock trades near its 52-week high of $0.18, with the micro-cap company currently valued at $35 million. InvestingPro analysis indicates the stock is currently undervalued. Following the transaction, Korenko directly owns 10,535,090 shares of Vivos Inc. The stock has shown relatively low volatility and has delivered a 17.89% return year-to-date. InvestingPro subscribers can access additional insights, including 3 more ProTips and detailed financial metrics about Vivos Inc’s performance and valuation.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.